Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Original Article: Breast Cancer"'
Autor:
Jagannath Dev Sharma, Sachin Khanna, Shubhra Ramchandani, Lopa Mudra Kakoti, Argha Baruah, Vinay Mamidala
Publikováno v:
South Asian Journal of Cancer
South Asian Journal of Cancer, Vol 10, Iss 04, Pp 220-224 (2021)
South Asian Journal of Cancer, Vol 10, Iss 04, Pp 220-224 (2021)
Objective The aim of the study is to see the prevalence of different molecular subtypes in breast cancer patients among two different age groups: ≤40 years and >40 years. Materials and Methods Retrospective study was conducted from January 2019 to
Autor:
Purvish M. Parikh, Gouri Shankar Bhattacharyya, Ghanshyam Biswas, Arvind Krishnamurty, Dinesh Doval, Anil Heroor, Sanjay Sharma, Ramakant Deshpande, Harit Chaturvedi, S. P. Somashekhar, Govind Babu, G. Krishna Reddy, Diptendra Sarkar, Chirag Desai, Hemant Malhotra, Nitesh Rohagi, Ajay Bapna, S. S. Alurkar, Prasad Krishna, S. V.S. Deo, Anurag Shrivastava, Prakash Chitalkar, Saroj Kumar Majumdar, Devanhalli Vijay, Aniket Thoke, K. S. Udupa, Jyoti Bajpai, G. K. Rath, Palanki Satya Dattatreya, Shailesh Bondarde, Shekhar Patil
Publikováno v:
South Asian Journal of Cancer
South Asian Journal of Cancer, Vol 10, Iss 04, Pp 213-219 (2021)
South Asian Journal of Cancer, Vol 10, Iss 04, Pp 213-219 (2021)
Breast cancer is a public health challenge globally as well as in India. Improving outcome and cure requires appropriate biomarker testing to assign risk and plan treatment. Because it is documented that significant ethnic and geographical variations
Autor:
Krishna Prasad, Suresh Ranga Rao, Manjeshwar Shrinath Baliga, Supreeth Kakkaje Chandran, Soniya Abraham, Thomas George
Publikováno v:
South Asian Journal of Cancer, Vol 09, Iss 03, Pp 130-135 (2020)
South Asian Journal of Cancer
South Asian Journal of Cancer
Purpose Development of cancer chemotherapy treatment-induced hyperglycemia/ diabetes (secondary diabetes) is a major problem and has never been reported from India. The present study was planned to ascertain this in women undergoing curative chemothe
Autor:
W.M. Jose, Anupama Rajanbabu, Reshu Agarwal, D K Vijaykumar, U. G. Unnikrishnan, Pavithran Keechilat
Publikováno v:
South Asian Journal of Cancer, Vol 09, Iss 03, Pp 136-140 (2020)
South Asian Journal of Cancer
South Asian Journal of Cancer
Background Pathological complete response (pCR) to neoadjuvant chemotherapy has emerged as a reliable surrogate marker for improved survival in breast cancer (BC), but its role as a surrogate end point is still controversial. Aims and Objectives The
Autor:
Ashish N Dhande, Siddhi Gaurish Sinai Khandeparkar, Avinash R Joshi, Aakriti Aggarwal, Neelam Mohanapure, Gargi Patil, Nidhi Pandya, Maithili Mandar Kulkarni
Publikováno v:
South Asian Journal of Cancer
South Asian Journal of Cancer, Vol 8, Iss 1, Pp 18-21 (2019)
South Asian Journal of Cancer, Vol 8, Iss 1, Pp 18-21 (2019)
Introduction: Breast cancer is the foremost cause of death in women worldwide with more than one million cases occurring annually. Aim: This study was conducted to study the stromal CD10 expression in breast carcinomas (BCa) and its correlation with
Autor:
Bindhu Joseph, Nisma Farooq, C. R. Vijay, Sabari Kumar, V. Lokesh, C. Ramesh, Kurian J Puthur
Publikováno v:
South Asian Journal of Cancer
South Asian Journal of Cancer, Vol 7, Iss 3, Pp 163-166 (2018)
South Asian Journal of Cancer, Vol 7, Iss 3, Pp 163-166 (2018)
Background and Purpose: To examine the feasibility of improving breast-conserving radiotherapy with simultaneous integrated boost (SIB) and analyzing the efficiency of forward versus inverse intensity-modulated radiotherapy (IMRT) techniques in provi
Autor:
Rekha V. Kumar, K C Lakshmaiah, Dipti Panwar, Champaka Gopal, Geetha Vikram Patil Okaly, Chennagiri Srinivasmurthy Premalata, Suma Mysore Narayana, Usha Amirtham, S. Krishnamurthy
Publikováno v:
South Asian Journal of Cancer
South Asian Journal of Cancer, Vol 7, Iss 1, Pp 7-10 (2018)
South Asian Journal of Cancer, Vol 7, Iss 1, Pp 7-10 (2018)
Aim: The aim of the study was to analyze the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) status over 7 years in South Indian women with breast cancer. Further analysis of a subgroup was done
Publikováno v:
South Asian Journal of Cancer
South Asian Journal of Cancer, Vol 7, Iss 4, Pp 215-218 (2018)
South Asian Journal of Cancer, Vol 7, Iss 4, Pp 215-218 (2018)
Background: In Oman, a higher proportion of patients presented with breast cancer are relatively young age and with an advanced stage. This could be due to lack of awareness and knowledge about breast cancer among young women. Aim: To assess the brea
Autor:
Surya Mishra, Tanuja Shet, Arun Chandrasekharan, Jyoti Bajpai, Sudeep Gupta, RA Badwe, Anant Ramaswamy
Publikováno v:
South Asian Journal of Cancer
South Asian Journal of Cancer, Vol 6, Iss 3, Pp 102-105 (2017)
South Asian Journal of Cancer, Vol 6, Iss 3, Pp 102-105 (2017)
Introduction: Biomarkers predictive of response to mechanistic target of rapamycin (mTOR) inhibitor, everolimus, in endocrine receptor (ER)-positive metastatic breast cancer (MBC) are a work in progress. We evaluated the feasibility of directly measu
Autor:
Sachin Hingmire, Purvish M. Parikh, Sujit Joshi, Rose Dawn Bharath, Mahesh B Sambhus, Dhananjay Kelkar
Publikováno v:
South Asian Journal of Cancer, Vol 6, Iss 2, Pp 47-50 (2017)
South Asian Journal of Cancer
South Asian Journal of Cancer
Background: The adjuvant short course 9-week trastuzumab combination therapy for human epidermal receptor 2 positive breast cancer patients may often be considered as a cost-effective and safe option and has important implications for the Indian subc